.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Teva
Merck
Express Scripts
McKesson
Harvard Business School
Moodys
Cerilliant
UBS
Dow

Generated: September 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 200153

« Back to Dashboard
NDA 200153 describes LIPTRUZET, which is a drug marketed by Merck Sharp Dohme and is included in one NDA. There are two patents protecting this drug. Additional details are available on the LIPTRUZET profile page.

The generic ingredient in LIPTRUZET is atorvastatin calcium; ezetimibe. There are sixty-one drug master file entries for this compound. Additional details are available on the atorvastatin calcium; ezetimibe profile page.

Summary for NDA: 200153

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:2
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:May 3, 2013TE:RLD:Yes
Patent:► SubscribePatent Expiration:Jan 8, 2017Product Flag?Substance Flag?Delist Request?Y
Patent:► SubscribePatent Expiration:Apr 25, 2017Product Flag?Substance Flag?Delist Request?

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:May 3, 2013TE:RLD:Yes
Patent:► SubscribePatent Expiration:Jan 8, 2017Product Flag?Substance Flag?Delist Request?Y

Expired Orange Book Patents for NDA: 200153



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Teva
Mallinckrodt
Fuji
Medtronic
Cipla
Chinese Patent Office
Citi
AstraZeneca
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot